Harmony Biosciences Holdings, Inc.(HRMY)
Biotechnology
Neuroscience Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-01-28 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Sale | -3,746 | -13.25%24,521 | $37.15 | $139,171 | View SEC filing | |
| 2026-01-20 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Sale | -20,961 | -100.00%0 | $35.92 | $752,833 | View SEC filing | |
| 2025-12-17 | Dayno Jeffrey M. PRESIDENT, CEO | Sale | -25,933 | -100.00%0 | $40.11 | $1,040,103 | View SEC filing | |
| 2025-12-09 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Sale | -20,000 | -100.00%0 | $39.54 | $790,896 | View SEC filing | |
| 2025-11-25 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Sale | -3,427 | -100.00%0 | $35.00 | $119,945 | View SEC filing | |
| 2025-08-19 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Sale | -21,573 | -100.00%0 | $36.50 | $787,378 | View SEC filing | |
| 2025-04-03 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Sale | -6,987 | -100.00%0 | $32.54 | $227,386 | View SEC filing | |
| 2025-03-05 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale | -4,869 | -100.00%0 | $32.67 | $159,090 | View SEC filing | |
| 2025-01-28 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale | -14,754 | -100.00%0 | $37.38 | $551,575 | View SEC filing | |
| 2025-01-28 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Sale | -1,775 | -100.00%0 | $38.05 | $67,547 | View SEC filing | |
| 2025-01-23 | Dayno Jeffrey M. PRESIDENT, CEO | Sale | -19,293 | -100.00%0 | $40.13 | $774,245 | View SEC filing | |
| 2025-01-23 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Sale | -25,000 | -100.00%0 | $40.18 | $1,004,598 | View SEC filing | |
| 2025-01-21 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale | -30,598 | -100.00%0 | $37.51 | $1,147,715 | View SEC filing | |
| 2025-01-16 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale | -10,507 | -100.00%0 | $37.01 | $388,841 | View SEC filing | |
| 2025-01-15 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale | -7,180 | -100.00%0 | $37.04 | $265,946 | View SEC filing | |
| 2024-11-05 | Gracias Antonio J. Director, 10% Owner | Sale | -4,600,000 | -41.01%6,618,033 | $30.30 | $139,391,500 | View SEC filing | |
| 2024-11-05 | Marshman Fund Trust II 10% Owner | Sale | -4,600,000 | -43.19%6,051,120 | $30.30 | $139,391,500 | View SEC filing | |
| 2024-10-31 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale | -21,496 | -100.00%0 | $40.47 | $870,018 | View SEC filing | |
| 2024-10-07 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale | -36,357 | -100.00%0 | $35.06 | $1,274,547 | View SEC filing | |
| 2024-10-02 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale | -400 | -100.00%0 | $40.19 | $16,077 | View SEC filing | |
| 2024-10-01 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale | -35,846 | -100.00%0 | $40.03 | $1,434,951 | View SEC filing | |
| 2024-09-30 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale | -200 | -100.00%0 | $40.05 | $8,009 | View SEC filing | |
| 2024-03-18 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale | -11,979 | -100.00%0 | $32.00 | $383,328 | View SEC filing | |
| 2024-03-11 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale | -194 | -100.00%0 | $32.00 | $6,208 | View SEC filing | |
| 2022-12-16 | Nielsen Jack Director | Sale | -2,834 | -0.11%2,571,024 | $59.96 | $169,927 | View SEC filing |
1-25 of 90